News


Resident News

MyHealth.US Awarded Best Wearable Technology Solution by Health Tech Digital

By JLABS

Read full story
Resident News

Holmusk partners with Merck to help improve outcomes for Diabetes & Prediabetes patients in Asia-Pacific

By JLABS

Read full story
Resident News

Nanowear Receives FDA 510(k) Clearance for SimpleSENSE, a Cloth-Based Wearable Remote Diagnostic Monitoring Platform

By JLABS

Read full story
Resident News

ProteoFormiX Awarded € 265K VLAIO Research Grant

By JLABS

Read full story
Resident News

S-Biomedic is Gearing up for Significant Growth

By JLABS

Read full story
Resident News

AlphaBiomics wins award to validate its IBD biologic therapy response predictor RxSelex

By JLABS

Read full story
Other news

Riding the Start-Up Roller Coaster: What It's Really Like to Be a Healthcare Entrepreneur

By Leena Rao

Read full story
Other news

IDEAYA Biosciences raised a $94M crossover Series B financing to develop next generation biomarker-enabled synthetic lethality therapies.

By Ideaya Biosciences

Read full story
Other news

Sirenas LLC. annouced today they have entered a muti-target research collaboration agreement with Bristol-Myers Squibb to deploy a drug discovery platform against undisclosed challenging therapeutic targets

By JLABS

Read full story
Other news

Nanovista Inc. closes $2.3 million seed round to advance its multimodal visualization agent towards clinical trials

By JLABS

Read full story
Other news

Imago BioSciences Receives FDA Approval of IND Application for the Treatment of Myeloid Malignancies

By JLABS

Read full story
Other news

Advanced Proteome Therapeutics Corporation (APC), a therapeutics discovery and development company, and ImmunoBiochem Corporation, announced they are entering into a Collaboration and Option agreement to develop superior antibody-drug conjugates

By JLABS

Read full story
Other news

JLABS TMC Company finds Growth in Shrinking Cells

By JLABS

Read full story
Other news

With a potential cure for lysosomal storage disorders in hand, Avrobio raises $60M to back gene therapy pipeline

By JLABS

Read full story
Other news

Avrobio, announced they have completed a $60M Series B round to back their gene therapy pipeline

By JLABS

Read full story